Feedback / Questions
Byqlovi (clobetasol propionate ophthalmic suspension) - AimMax Therap, Harrow Health
https://www.businesswire.com/news/home/20250609515264/en/Harrow-Acquires-U.S.-Commercial-Rights-to-BYQLOVI-Clobetasol-Propionate-Ophthalmic-Suspension-0.05-from-Formosa-Pharmaceuticals
Jun 9, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next